
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **FABP7**: Fatty acid binding protein 7, involved in fatty acid uptake, transport, and metabolism. Often associated with neural stem cells and astrocytes.<br>- **MT1H, MT1G**: Metallothioneins, involved in metal ion binding and detoxification. They play roles in cellular protection against oxidative stress.<br>- **RAMP2**: Receptor activity-modifying protein 2, involved in modulating receptor activity, particularly in the context of the cardiovascular system.<br>- **NDRG2**: N-myc downstream-regulated gene 2, involved in stress responses, cell growth, and differentiation.<br>- **MARCKSL1**: Myristoylated alanine-rich C-kinase substrate-like 1, involved in cell motility and cytoskeletal organization.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT15, KRT19**: Keratins, structural proteins in epithelial cells. KRT19 is often associated with epithelial cells, including those in the breast.<br>- **SIX3**: A transcription factor involved in development, particularly in the brain and eye, but also expressed in some epithelial tissues.<br>- **SOX4**: A transcription factor involved in development and differentiation, often associated with progenitor and stem cells.<br>- **NFIB**: Nuclear factor I B, a transcription factor involved in development and differentiation, particularly in the brain and lung.<br><br>### Step 3: Cross-reference Known Databases<br>Using scRNA-seq databases such as the Human Cell Atlas and literature, we can cross-reference these markers:<br>- **KRT19** and **KRT15** are strongly indicative of epithelial cells, particularly luminal epithelial cells in the breast.<br>- **FABP7** is often expressed in neural tissues but can also be found in certain cancer stem cells.<br>- **SOX4** and **NFIB** are associated with progenitor and stem-like states, which can be relevant in cancer contexts.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of **KRT19**, **KRT15**, and other epithelial markers, the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely breast epithelial cells.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: High expression of **KRT19** and **KRT15** suggests luminal epithelial cells, which are common in breast tissue.<br>2. **Basal/Myoepithelial Cells**: While less likely due to the lack of specific basal markers like KRT5 or KRT14, the presence of general epithelial markers could still suggest this subtype.<br>3. **Cancer Stem-like Cells**: The presence of **SOX4**, **FABP7**, and other stem/progenitor markers could indicate a stem-like or progenitor state within the cancer context.<br><br>**Most Likely Subtype**: **Luminal Epithelial Cells** are the most likely subtype due to the strong expression of luminal markers like **KRT19** and **KRT15**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the high expression of keratin markers such as **KRT19** and **KRT15**, which are characteristic of luminal epithelial cells in the breast. The presence of markers like **SOX4** and **FABP7** also suggests a potential stem-like or progenitor state, which is relevant in the context of cancer.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    To validate the annotation result, let's follow the outlined steps:<br><br>### Step 1: Marker Consistency<br>- **FABP7**, **MT1H**, **MT1G**, **RAMP2**, **NDRG2**, **MARCKSL1**, **KRT15**, **KRT19**, **SIX3**, **SOX4**, and **NFIB** are all present in the provided marker list. This confirms that the markers used in the annotation are consistent with the provided list.<br><br>### Step 2: Mixed Cell Type Consideration<br>- The annotation suggests the presence of luminal epithelial cells, basal/myoepithelial cells, and cancer stem-like cells. The presence of **KRT19** and **KRT15** strongly supports the identification of luminal epithelial cells.<br>- The presence of **SOX4** and **FABP7** suggests a potential stem-like or progenitor state, which is relevant in the context of cancer.<br>- The annotation does not strongly support the presence of basal/myoepithelial cells due to the lack of specific basal markers like **KRT5** or **KRT14**.<br><br>### Conclusion<br>The annotation is consistent with the provided marker list and the identified cell type is supported by the markers. The potential presence of cancer stem-like cells is noted, but the primary identification of luminal epithelial cells is well-supported by the data.<br><br>Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>basal/myoepithelial cells</li><li>cancer stem-like cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a solid understanding of the single-cell data, particularly in the context of human breast cancer. The analysis correctly identifies the main cell type as epithelial cells, with a focus on luminal epithelial cells, which is well-supported by the presence of key markers such as KRT19 and KRT15. These markers are indeed indicative of luminal epithelial cells in breast tissue, aligning with the cluster origin of human breast cancer.<br><br>The annotation also considers the potential presence of cancer stem-like cells, supported by markers like SOX4 and FABP7. This is a reasonable consideration given the context of cancer, where stem-like properties can be relevant. However, the suggestion of basal/myoepithelial cells is less convincing due to the absence of specific basal markers like KRT5 or KRT14, which the annotation itself acknowledges.<br><br>The analysis effectively balances the use of multiple markers, considering both structural proteins and transcription factors, which provides a comprehensive view of the cell types present. The annotation process also cross-references known databases, adding credibility to the conclusions drawn.<br><br>One area for improvement could be a more explicit consideration of the rank of the markers. While the analysis does focus on key markers, it could benefit from a clearer emphasis on the most highly ranked markers, as these are typically more indicative of the cell type.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and captures the general picture of the cell populations present in the dataset. There are no obvious misclassifications, and the analysis is thorough and well-reasoned.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    